Two licensed clinical social workers who operate separate therapy businesses in Hagerstown, Md., have co-created a self-care course for professionals who deal with trauma. "[W]e have a lot of clinicians in our county that work hard to serve our populations, and they need help too with the specialty of trauma because it's often very large and very big and very hard to wrap your hands around," says Danielle Hudak, who developed "Helpers Armor" with Jennifer Canby.
Two Democratic lawmakers are proposing substantial increases in funding to raise Illinois' low national ranking in mental health services. The measures call for outcome-based payments to providers rather than flat fees.
Louisiana's lawmakers, governor and first lady are feeling, and praising, the influence of former foster children enrolled in a legislative internship program run by the nonprofit Louisiana Institute for Children in Families. A proposed extension of foster care to age 21 from the current maximum age of 18 is a key issue for the interns.
Researchers found that deceased humans and live animals with Alzheimer's disease had significantly weaker mitophagy -- the cleaning system for brain cells -- but animal models that received active substances meant to improve mitophagy were almost free of Alzheimer's symptoms. The findings in Nature Neuroscience may prompt the development of new Alzheimer's treatments aimed at the mitophagy process, researchers said.
Glioblastoma patients with methylated MGMT promoter who received chemotherapy with temozolomide and CCNU, or lomustine, had nearly 50% improved survival with well-tolerated side effects, compared with those who took temozolomide alone, German researchers reported in The Lancet. However, the findings showed that the chemo combo didn't benefit other patients with glioblastoma.
Researchers found that advanced age, stage and Charlson Comorbidity Index of at least 1 were associated with increased odds of diffuse large B-cell lymphoma-specific mortality in older adults. The findings in the journal Cancer also showed that women and those with higher socioeconomic status had lower odds of DLBCL-related death after therapy, while those who received rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone had a 14% and 18.6% likelihood of DLBCL-related mortality at two years and five years, respectively, with the risk leveling off afterward.
The FDA gave Mirada Medical 510(k) clearance for its Simplicit90Y dosimetry software, which aims to bolster dosimetry planning and post-treatment validation standardization and reproducibility in transarterial radioembolization procedures that use yttrium-90. Simplicit90Y features image manipulation, digital processing, quantification analysis and other tools for medical image review and reporting, which help provide personalized therapies for liver cancer patients scheduled for TARE procedures.
Health care trade associations and other groups are asking the FDA to clarify its proposed rule allowing institutional review boards an exception to obtaining informed consent from patients during minimal-risk studies. Public Citizen, a nonprofit advocacy group, told the agency it's "deeply concerned that once the FDA finalizes the proposed rule, clinical investigators will inappropriately seek, and IRBs inappropriately will grant, waivers of informed consent for clinical investigations that involve greater than minimal risk."
CHIME released a statement addressed to a Senate Committee on Commerce, Science and Transportation subcommittee urging the group to commit to adopting 5G technology and pointing out its potential benefits to health care. CHIME said emerging technologies such as telehealth and big data stand to benefit from the removal of "today's bandwidth limitations."
CVS debuted three new stores called HealthHUBs that focus on personal wellness, including offering nutrition counseling by a dietitian and rooms for exercise and nutrition classes. Walgreens also has retrofitted stores to offer customers more health services, such as optical services and lab testing.